Australia markets closed
  • ALL ORDS

    7,141.00
    -94.50 (-1.31%)
     
  • AUD/USD

    0.6314
    -0.0054 (-0.84%)
     
  • ASX 200

    6,943.40
    -89.80 (-1.28%)
     
  • OIL

    88.89
    +0.07 (+0.08%)
     
  • GOLD

    1,842.10
    -5.10 (-0.28%)
     
  • Bitcoin AUD

    43,699.94
    -1,150.72 (-2.57%)
     
  • CMC Crypto 200

    589.46
    -14.08 (-2.33%)
     

Is CRISPR Therapeutics Stock a Buy Now?

Is CRISPR Therapeutics Stock a Buy Now?

A year ago, CRISPR Therapeutics' (NASDAQ: CRSP) stock was trading for $46 per share. As of Tuesday afternoon, the biotech stock was at $64. While other investors have begun to catch on to the upside of the company, it's still a clinical-stage biopharmaceutical company -- that is, one with no marketed therapies yet.